Ventyx Biosciences Inc
NASDAQ:VTYX 3:59:52 PM EDT
Earnings Announcements
Ventyx Biosciences Reports Full Year 2021 Financial Results
Published: 03/23/2022 12:46 GMT
Ventyx Biosciences Inc (VTYX) - Ventyx Biosciences Reports Full Year 2021 Financial Results and Highlights Recent Corporate Progress.
Ventyx Biosciences - Believe Current Cash, Cash Equivalents and Marketable Securities Sufficient to Fund Planned Operations Into First Half of 2024.
Ventyx Biosciences - Believe Current Cash, Cash Equivalents and Marketable Securities Sufficient to Fund Planned Operations Into First Half of 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.46
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.48
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.46
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.48
More details on our Analysts Page.